Samuel Frank
Samuel Frank
Beth Israel Deaconess Medical Center
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
The Parkinson progression marker initiative (PPMI)
K Marek, D Jennings, S Lasch, A Siderowf, C Tanner, T Simuni, C Coffey, ...
Progress in neurobiology 95 (4), 629-635, 2011
The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy
VL Towle, J Bolaños, D Suarez, K Tan, R Grzeszczuk, DN Levin, ...
Electroencephalography and clinical neurophysiology 86 (1), 1-6, 1993
Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease
JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ...
JAMA neurology 70 (10), 1277-1287, 2013
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
Treatment of Huntington’s disease
S Frank
Neurotherapeutics 11, 153-160, 2014
Roles of intensity and duration of nocturnal exercise in causing phase delays of human circadian rhythms.
OM Buxton, SA Frank, M L'Hermite-Balériaux, R Leproult, FW Turek, ...
American Journal of Physiology-Endocrinology And Metabolism 273 (3), E536, 1997
Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
S Frank
BMC neurology 9 (1), 1-10, 2009
Effect of deutetrabenazine on chorea among patients with Huntington disease: a randomized clinical trial
S Frank, CM Testa, D Stamler, E Kayson, C Davis, MC Edmondson, ...
Jama 316 (1), 40-50, 2016
The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations
IH Richard, S Frank, MP McDermott, H Wang, AW Justus, KA LaDonna, ...
Cognitive and behavioral neurology 17 (4), 201-207, 2004
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
A McGarry, M McDermott, K Kieburtz, EA de Blieck, F Beal, K Marder, ...
Neurology 88 (2), 152-159, 2017
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: relationships among biomarkers and Parkinson's disease features
JG Goldman, H Andrews, A Amara, A Naito, RN Alcalay, LM Shaw, ...
Movement Disorders 33 (2), 282-288, 2018
Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
S Frank
Neuropsychiatric disease and treatment, 657-665, 2010
Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers
SYH Kim, S Frank, R Holloway, C Zimmerman, R Wilson, K Kieburtz
Archives of Neurology 62 (9), 1357-1360, 2005
Advances in the pharmacological management of Huntington’s disease
S Frank, J Jankovic
Drugs 70, 561-571, 2010
Common SNP-based haplotype analysis of the 4p16. 3 Huntington disease gene region
JM Lee, T Gillis, JS Mysore, EM Ramos, RH Myers, MR Hayden, ...
The American Journal of Human Genetics 90 (3), 434-444, 2012
Efficacy of nilotinib in patients with moderately advanced Parkinson disease: a randomized clinical trial
T Simuni, B Fiske, K Merchant, CS Coffey, E Klingner, C Caspell-Garcia, ...
JAMA neurology 78 (3), 312-320, 2021
Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and …
ML Alosco, Y Tripodis, NG Fritts, A Heslegrave, CM Baugh, S Conneely, ...
Alzheimer's & Dementia 14 (9), 1159-1170, 2018
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
S Frank, W Ondo, S Fahn, C Hunter, D Oakes, S Plumb, F Marshall, ...
Clinical neuropharmacology 31 (3), 127-133, 2008
An approach to evaluating therapeutic misconception
SYH Kim, L Schrock, RM Wilson, SA Frank, RG Holloway, K Kieburtz, ...
Irb 31 (5), 7, 2009
HDQLIFE: Development and assessment of health-related quality of life in Huntington disease (HD)
NE Carlozzi, SG Schilling, JS Lai, JS Paulsen, EA Hahn, JS Perlmutter, ...
Quality of Life Research 25, 2441-2455, 2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20